Success rates of pulpotomy in mature permanent teeth: A literature review

References

1. Ritwik P. A review of pulp therapy for primary and immature permanent teeth. J Calif Dent Assoc. 2013;41(8):585–95.
2. AAE position statement on vital pulp therapy. J Endod.2021; 47(9):1340–4.
3. Philip N, Suneja B. Minimally invasive endodontics: a new era for pulpotomy in mature permanent teeth. Br Dent J. 2022;233(12):1035–41. Upadhyay et al / IP Indian Journal of Conservative and Endodontics 2025;10(2):90–95 95
4. Simon DS. Endodontic case difficulty assessment: the team approach.Gen Dent. 1999;47(4):340–4.
5. Duncan HF, Galler KM, Tomson, PL Simon S, El-Karim I, Kundzina R et al. European society of endodontology position statement: management of deep caries and the exposed pulp. Int Endod J. 2019; 52(7): 923–34.
6. Taha NA, About I, Sedgley CM, Messer HH. Conservative management of mature permanent teeth with carious pulp exposure. J Endod. 2020;46(9S):S33–41.
7. Galicia JC, Peters OA. Proposal for a new diagnostic terminology to describe the status of the dental pulp. Int Endod J. 2021;54(8):1415–
8. Aguilar P, Linsuwanont P. Vital pulp therapy in vital permanent teeth with cariously exposed pulp: A systematic review. J Endod. 2011;37(5):581–7.
9. Alqaderi H, Lee CT, Borzangy S, Pagonis TC. Coronal pulpotomy for cariously exposed permanent posterior teeth with closed apices: A systematic review and meta-analysis. J Dent. 2016:44:1–7.
10. Li Y, Sui B, Dahl C, Bergeron B, Shipman P, Niu L et al. Pulpotomy for carious pulp exposures in permanent teeth: A systematic review and meta-analysis. Dent J. 2019;84(1):1–8.
11. Cushley S, Duncan HF, Lappin MJ, Tomson PL, Lundy FT, Cooper P et al. Pulpotomy for mature carious teeth with symptoms of irreversible pulpitis: A systematic review. J Dent. 2019;88(1):103158.
12. Asgary S, Hassanizadeh R, Torabzadeh H, Eghbal MJ. Treatment outcomes of 4 vital pulp therapies in mature molars. J Endod. 2018;44(4):529–35.
13. Ramani A, Sangwan P, Tewari S, Duhan J, Mittal S, Kumar V. Comparative evaluation of complete and partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: A randomized clinical trial. Int Endod J. 2022;55(5):430–40.
14. Daniele L. Mineral Trioxide Aggregate (MTA) direct pulp capping: 10 years clinical results. G Ital Endod. 2017;31(1):48–57.
15. Trairatvorakul C, Koothiratrakarn A. Calcium hydroxide partial pulpotomy is an alternative to formocresol pulpotomy based on a 3- year randomized trial. Int J Paediatr Dent. 2012;22(5):382–9.
16. Eghbal MJ, Asgary S, Baglue RA, Parirokh M, Ghoddusi J. MTA pulpotomy of human permanent molars with irreversible pulpitis. Aust Endod J. 2009;35(1):4–8.
17. Saqib M, Ahmed MA, Jouhar R, Hemani A, Ziaullah. Pulpotomy: assessment of clinical outcome in mature permanent teeth using mineral trioxide aggregate. Professional Med J. 2017;24(12):1909–
18. Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis. Int Endod J. 2018;51(8):819–28.
19. Kang CM, Sun Y, Song JS, Pang NS, Roh BD, Lee CY, et al. A randomized controlled trial of various MTA materials for partial pulpotomy in permanent teeth. J Dent. 2017;60(3):8–13.
20. Tan SY, Yu VSH, Lim KC, Tan BCK, Neo CLJ, Shen L, et al. Long- term pulpal and restorative outcomes of pulpotomy in mature permanent teeth. J Endod. 2020;46(3):383–90.
21. Taha NA, Hamdan AM, Al-Hiyasat AS. Coronal discoloration induced by calcium silicate-based cements used in full pulpotomy in mature permanent molars: A randomized clinical trial. Clin Oral Investig. 2023;27(4):1723–30.
22. Simon S, Perard M, Zanini M, Smith AJ, Charpentier E, Djole SX et al. Should pulp chamber pulpotomy be seen as a permanent treatment? Some preliminary thoughts. Int Endod J. 2013;46(1):79–
23. Linsuwanont P, Wimonsutthikul K, Pothimoke U, Santiwong B. Treatment outcomes of mineral trioxide aggregate pulpotomy in vital permanent teeth with carious pulp exposure: The retrospective study. J Endod. 2017;43(1):225–30.
24. Anta S, Diouma N, Ousmane NS, Fatou LB, Florence F, Babacar T. Evaluation of complete pulpotomy with biodentine on mature permanent molars with signs and symptoms of symptomatic irreversible pulpitis: 12-months follow-up. J Endod. 2022;48(3):312–
25. Jalan AL, Warhadpande MM, Dakshindas DM. A comparison of human dental pulp response to calcium hydroxide and Biodentine as direct pulp-capping agents. J Conserv Dent. 2017;20(2):129–33.
26. Tziafa C, Koliniotou-Koumpia E, Papadimitriou S, Tziafas D. Dentinogenic responses after direct pulp capping of miniature swine teeth with Biodentine. J Endod. 2014;40(12):1967–71.
27. Zarrabi MH, Javidi M, Jafarian AH, Joushan B. Histologic assessment of human pulp response to capping with mineral trioxide aggregate and a novel endodontic cement. J Endod. 2010;36(11):1778–81.
28. Asgary S, Eghbal MJ. The effect of pulpotomy using a calcium- enriched mixture cement versus one-visit root canal therapy on postoperative pain relief in irreversible pulpitis: A randomized clinical trial. Odontol. 2010;98(2):126–33.
29. Sharaan M, Ali A. Mineral Trioxide Aggregate vs Calcium-Enriched Mixture Pulpotomy in Young Permanent Molars with a Diagnosis of Irreversible Pulpitis: A Randomized Clinical Trial. Iran Endod J. 2022;17(3):106–13.
30. Tabarsi B, Parirokh M, Eghbal MJ, Haghdoost AA, Torabzadeh H, Asgary S. A comparative study of dental pulp response to several pulpotomy agents. Int Endod J. 2010;43(7):565–71.
31. Ahangari Z, Naseri M, Jalili M, Mansouri Y, Mashhadiabbas F, Torkaman A. Effect of propolis on dentin regeneration and the potential role of dental pulp stem cell in Guinea pigs. Cell J. 2012;13(4):223–8.
32. Wassel M, Hamdy D, Elghazawy R. Evaluation of four vital pulp therapies for primary molars using a dual-cured tricalcium silicate (TheraCal PT): One-year results of a non-randomized clinical trial. J Clin Pediatr Dent. 2023;47(2):10–22.
33. Doranala S, Surakanti JR, Vemisetty H, Loka SR, Sudireddy K, Punna R. Comparative assessment of titanium-prepared platelet-rich fibrin, Endosequence root repair material, and calcium hydroxide as pulpotomy agents in permanent teeth with irreversible pulpitis: A randomized controlled trial. J Conserv Dent. 2021;24(6):606–10
34. Govindaraj N, Shah K, Subramaniam P, Gupta M. Evaluation of bioactive glass and hydroxyapatite crystals as pulpotomy agents in primary molars: A clinical study. Contemp Pediatr Dent. 2020:1(1):42–51.
35. Orhan E, Uysal AC, Başer E, Keskin D, Demiroglu-Yakut C. The effect of intradermal administration of inactive platelet-rich plasma on flap viability in rats. Actas Cir Bras. 2017;32(4):280–6.
36. Mansour NK, Hashem MA, Sharraan M, Fayad DM,. Effect of injectable-platelet rich fibrin on marginal adaptation of bioactive materials used as direct pulp capping; an experimental animal study. Dent Sci updates. 2021;2(2):185–95.
37. Shobana S, Kavitha M, Srinivasan N. Efficacy of platelet rich plasma and platelet rich fibrin for direct pulp capping in adult patients with carious pulp exposure- A randomised controlled trial. Euro Endod J. 2022;7(2):114–21.
38. Beltagy TM. Platelet-rich Plasma Pulpotomy in Primary Molars. Egypt Dent J. 2018;64(2):159–70.
39. Gupta G, Rana V, Srivastava N, Chandna P. Laser pulpotomy– An effective alternative to conventional techniques: a 12 months clinicoradiographic study. Int J Clin Pediatr Dent. 2015;8(1):18–21.
40. Asgary S. Two vital pulp therapy techniques for treating a molar with established irreversible pulpitis and condensing osteitis. J Dent Sci. 2023;18(4):1948–9.
41. RojaRamya KS, Chandrasekhar R, Uloopi KS, Vinay C. Treatment Outcomes of Pulpotomy with Propolis in Comparison with MTA in Human Primary Molars: A 24-month Follow-up Randomized Controlled Trial. Int J Clin Pediatr Dent. 2022;15(Suppl 1):S3–7.